The reference with the highest burst strength (45.52) is the seminal article “Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation,” published in the New England Journal of Medicine by Paul B. Chapman et al. (Chapman et al., 2011). This evidence concerns the gene BRAF and melanoma.